Masahiro Kondo Selected Research

benazeprilat

6/2003

An angiotensin converting enzyme inhibitor, benazepril can be transformed to an active metabolite, benazeprilat, by the liver of dogs with ascitic pulmonary heartworm disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Kondo Research Topics

Disease

7	Pain (Aches) 01/2020 - 05/2007
4	Neoplasms (Cancer) 01/2020 - 11/2012
3	Necrosis 01/2021 - 09/2009
2	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2018
2	Rheumatoid Arthritis 01/2021 - 12/2014
2	Multiple Myeloma 11/2020 - 01/2020
2	Tumor Lysis Syndrome 11/2020 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2017
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 05/2017
2	Neutropenia 01/2018 - 11/2012
2	Hypersensitivity (Allergy) 09/2017 - 06/2008
2	Inflammation (Inflammations) 09/2017 - 01/2013
2	Osteoarthritis 01/2016 - 05/2015
2	Arthritis (Polyarthritis) 01/2015 - 01/2014
2	Facial Pain (Myofacial Pain) 01/2012 - 02/2009
1	Pneumonia (Pneumonitis) 02/2022
1	Cough 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Ascites 01/2021
1	Rheumatoid Nodule 01/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021
1	Pericardial Effusion 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2018
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 09/2018
1	Hepatitis B 01/2018
1	Infections 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Urethral Neoplasms (Urethral Cancer) 05/2017
1	Solitary Kidney 05/2017
1	Inappropriate ADH Syndrome (SIADH) 05/2017
1	Dermatomyositis (Dermatopolymyositis) 10/2014
1	Experimental Arthritis 01/2014
1	Erythema 01/2014

Drug/Important Bio-Agent (IBA)

5	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 01/2007
3	Bortezomib (Velcade)FDA Link 11/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 11/2012
3	Cisplatin (Platino)FDA LinkGeneric 05/2017 - 01/2014
2	SteroidsIBA 02/2022 - 01/2021
2	tofacitinibIBA 01/2021 - 12/2014
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	Gemcitabine FDA Link 01/2018 - 05/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2012
2	Collagen Type II (Type II Collagen)IBA 01/2015 - 01/2014
2	InterleukinsIBA 12/2014 - 09/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 09/2009
2	CytokinesIBA 01/2013 - 09/2009
2	AMPA Receptors (AMPA Receptor)IBA 01/2012 - 03/2011
2	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 01/2011 - 05/2008
2	Propofol (Diprivan)FDA LinkGeneric 06/2009 - 05/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Etanercept (Enbrel)FDA Link 01/2021
1	Proteasome InhibitorsIBA 11/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	Thalidomide (Thalomid)FDA Link 01/2020
1	Therapeutic UsesIBA 09/2018
1	pazopanib FDA Link 09/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	fludarabineIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	taxaneIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 09/2017
1	AnkyrinsIBA 09/2017
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 09/2017
1	tryptophyltryptophanIBA 09/2017
1	Protein Kinase C-epsilonIBA 09/2017
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 09/2017
1	Metabotropic Glutamate 5 ReceptorIBA 09/2017
1	Vasopressins (Vasopressin)IBA 05/2017
1	Platinum Compounds (Compounds, Platinum)IBA 05/2017
1	glycolic acid (glycolate)IBA 01/2016
1	NestinIBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	Janus Kinase InhibitorsIBA 12/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014
1	Interleukin-10 (Interleukin 10)IBA 12/2014
1	Janus KinasesIBA 12/2014
1	tocilizumab (atlizumab)FDA Link 10/2014

Therapy/Procedure

7	Therapeutics 02/2022 - 01/2018
7	Drug Therapy (Chemotherapy) 01/2020 - 11/2012
2	Renal Dialysis (Hemodialysis) 01/2018 - 11/2012
1	Plasma Exchange 02/2022
1	Antineoplastic Combined Chemotherapy Protocols 01/2018
1	Nephroureterectomy 05/2017
1	Chemoprevention 01/2017
1	Injections 01/2014